Search research articles
Contact Us
Filters
Showing results (1-10 of 76) with videos related to
Page
of 8
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
December 29, 1999
Update on the treatment of neutropenia in HIV-infected patients: introduction
S C Piscitelli
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation
|
May 22, 2001
Antiretroviral pharmacology issues and management
S C Piscitelli
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
December 3, 1999
Syndromes of abnormal fat redistribution and metabolic complications in HIV-infected patients
K Struble, S C Piscitelli
AIDS Patient Care and Stds
|
October 8, 2004
An update on drug interactions with zidovudine
S C Piscitelli, M A Polis
The New England Journal of Medicine
|
March 29, 2001
Interactions among drugs for HIV and opportunistic infections
S C Piscitelli, K D Gallicano
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
March 1, 1995
Role of interleukin-2 in managing infection with the human immunodeficiency virus
S C Piscitelli, J R Minor
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 1, 1993
New oral macrolide and fluoroquinolone antibiotics: an overview of pharmacokinetics, interactions, and safety
K A Rodvold, S C Piscitelli
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 21, 2007
Drug-cytokine interactions: mechanisms and clinical implications
W G Reiss, S C Piscitelli
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 15, 1996
Thalidomide in diseases associated with human immunodeficiency virus infection
J R Minor, S C Piscitelli
Drug Safety
|
January 27, 2000
A risk-benefit assessment of interleukin-2 as an adjunct to antiviral therapy in HIV infection
S C Piscitelli, N Bhat, A Pau
Page
of 8
Search research articles
Search
Showing results (1-10 of 76) with videos related to
Sort By:
Page
of 8
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
December 29, 1999
Update on the treatment of neutropenia in HIV-infected patients: introduction
S C Piscitelli
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation
|
May 22, 2001
Antiretroviral pharmacology issues and management
S C Piscitelli
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
December 3, 1999
Syndromes of abnormal fat redistribution and metabolic complications in HIV-infected patients
K Struble, S C Piscitelli
AIDS Patient Care and Stds
|
October 8, 2004
An update on drug interactions with zidovudine
S C Piscitelli, M A Polis
The New England Journal of Medicine
|
March 29, 2001
Interactions among drugs for HIV and opportunistic infections
S C Piscitelli, K D Gallicano
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
March 1, 1995
Role of interleukin-2 in managing infection with the human immunodeficiency virus
S C Piscitelli, J R Minor
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 1, 1993
New oral macrolide and fluoroquinolone antibiotics: an overview of pharmacokinetics, interactions, and safety
K A Rodvold, S C Piscitelli
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 21, 2007
Drug-cytokine interactions: mechanisms and clinical implications
W G Reiss, S C Piscitelli
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 15, 1996
Thalidomide in diseases associated with human immunodeficiency virus infection
J R Minor, S C Piscitelli
Drug Safety
|
January 27, 2000
A risk-benefit assessment of interleukin-2 as an adjunct to antiviral therapy in HIV infection
S C Piscitelli, N Bhat, A Pau
Page
of 8